These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1756 related items for PubMed ID: 8242665

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes.
    Asano T, McWatters A, An T, Matsushima K, Kleinerman ES.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1032-9. PubMed ID: 8113959
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Muramyl tripeptide phosphatidylethanolamine encapsulated in liposomes stimulates monocyte production of tumor necrosis factor and interleukin-1 in vitro.
    Maeda M, Knowles RD, Kleinerman ES.
    Cancer Commun; 1991 Feb; 3(10-11):313-21. PubMed ID: 1722107
    [Abstract] [Full Text] [Related]

  • 6. Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy.
    Asano T, Kleinerman ES.
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):286-92. PubMed ID: 8280710
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
    Kleinerman ES.
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):927-38. PubMed ID: 7490249
    [Abstract] [Full Text] [Related]

  • 10. Induction of serum tumor necrosis factor-alpha and interleukin-6 activity by liposome-encapsulated muramyl tripeptide-phosphatidylethanolamine (L-MTP-PE) in normal cats.
    Fox LE, King RR, Shi F, Kurzman ID, MacEwen EG, Kubilis PS.
    Cancer Biother; 1994 Aug; 9(4):329-40. PubMed ID: 7719380
    [Abstract] [Full Text] [Related]

  • 11. Influence of chemotherapy administration on monocyte activation by liposomal muramyl tripeptide phosphatidylethanolamine in children with osteosarcoma.
    Kleinerman ES, Snyder JS, Jaffe N.
    J Clin Oncol; 1991 Feb; 9(2):259-67. PubMed ID: 1988574
    [Abstract] [Full Text] [Related]

  • 12. Liposomal muramyl tripeptide upregulates adhesion molecules on the surface of human monocytes.
    Asano T, McIntyre BW, Bednarczyk JL, Wygant JN, Kleinerman ES.
    Oncol Res; 1995 Feb; 7(5):253-7. PubMed ID: 8534931
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lack of production of interleukin 1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide.
    Tandon P, Utsugi T, Sone S.
    Cancer Res; 1986 Oct; 46(10):5039-44. PubMed ID: 3489519
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combination therapy with ifosfamide and liposome-encapsulated muramyl tripeptide: tolerability, toxicity, and immune stimulation.
    Kleinerman ES, Meyers PA, Raymond AK, Gano JB, Jia SF, Jaffe N.
    J Immunother Emphasis Tumor Immunol; 1995 Apr; 17(3):181-93. PubMed ID: 7613644
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.
    Kleinerman ES, Gano JB, Johnston DA, Benjamin RS, Jaffe N.
    Am J Clin Oncol; 1995 Apr; 18(2):93-9. PubMed ID: 7900714
    [Abstract] [Full Text] [Related]

  • 18. ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity.
    Worth LL, Jia SF, An T, Kleinerman ES.
    Cancer Immunol Immunother; 1999 Sep; 48(6):312-20. PubMed ID: 10473806
    [Abstract] [Full Text] [Related]

  • 19. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
    Fogler WE, Fidler IJ.
    Int J Immunopharmacol; 1987 Sep; 9(2):141-50. PubMed ID: 3583507
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 88.